Home › Compare › ZUMRF vs ABBV
ZUMRF yields 4000.00% · ABBV yields 3.06%● Live data
📍 ZUMRF pulled ahead of the other in Year 1
Combined, ZUMRF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZUMRF + ABBV for your $10,000?
ZoomerMedia Limited operates as a multimedia company in Canada. The company operates through five segments: Television, Radio, Print, Royalty, and Other Operations. It is involved in the business of television, radio, magazine, Internet, conferences, and trade shows primarily for the 45 plus age group. The company's television properties include Vision TV, a multi-cultural and multi-faith specialty television service; ONE TV, which offers fitness, healthy living, and entertainment programs; JoyTV and Faith TV, channels for broadcasting Christian and local programming; and TVL Channel 5, a linear television channel guide available to households. It also operates various radio stations, such as CFMZ-FM Toronto and CFMX-FM Cobourg; CFMO-FM Collingwood; CFZM-AM 740 Toronto and CFZM-FM 96.7FM Toronto Zoomer Radio; and Toronto's Timeless Hits station. In addition, the company publishes Zoomer magazine; and On The Bay Magazine, a regional lifestyle magazine published quarterly for the 20 towns and villages of Southern Georgian By, Ontario, as well as Tonic magazine, a regional health and wellness magazine published for every two months and distributed in Toronto. Further, it provides online content services targeting the 45plus age group primarily through EverythingZoomer.com and blogTO.com, as well as CARP.ca, VisionTV.ca, ZoomerRadio.ca, and ClassicalFM.ca. Additionally, the company produces ZoomerShows, an annual consumer shows directed to the Zoomer demographic; and ideaCity, an annual Canadian conference. ZoomerMedia Limited was founded in 2008 and is based in Toronto, Canada.
Full ZUMRF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.